Clinical data | |
---|---|
ATC code |
|
Identifiers | |
|
|
Synonyms | MDL-100,907 |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
ChEMBL | |
ECHA InfoCard | 100.123.797 |
Chemical and physical data | |
Formula | C22H28FNO3 |
Molar mass | 373.46 g/mol |
3D model (Jmol) | |
|
Volinanserin (INN) (developmental code name MDL-100,907) is a highly selective 5-HT2A receptor antagonist that is frequently used in scientific research to investigate the function of the 5-HT2A receptor. It was also tested in clinical trials as a potential antipsychotic,antidepressant, and treatment for insomnia but was never marketed.